Levitation option still valid for Wile E. Coyote
Fresh from the Department of Whistling Past the Graveyard in today’s VentureWire:
Back in the real world, seven life-science IPOs have gone down in flames so far this year. An eighth startup, robotic-surgery maker MAKO Surgical, just slashed its offering price.
Brace yourselves for the SPAC attack
Life-science IPOs may be hitting the wall — so far this year, seven biotech and medical-device startups have yanked their offerings — but one part of the IPO market is booming. That’s the field of “special-purpose acquisition corporations,” or SPACs, which are essentially blank-check companies… Continue Reading
Life-science IPOs hit the skids
Last year was a tough one for IPOs, as Matt noted earlier, and so far this year looks even worse. Aptamer-drug maker Archemix today became the third life-science startup this month to withdraw or postpone an IPO, and the sixth so far this year. We… Continue Reading
Life sciences briefing: Friday, Dec. 7, 2007
TODAY’S HEADLINES:
Essex Woodlands raising $1.25B for life-scences fund (VentureWire, sub req’d)
SCP VitaLife raises $122M for life sciences (VW)
Pantec Bio draws CHF 6.3M for laser-drug delivery (release)
Essex Woodlands raising $1.25B for life-scences fund — Essex Woodlands Health Ventures, a Palo Alto, Calif., VC firm, is in… Continue Reading